Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-25 @ 2:09 AM
NCT ID:
NCT02964260
Eligibility Criteria:
Inclusion Criteria:
* Age between 18 to 70 years with estimated survival over 3 months
* Number of tumors \< 3
* Diameter of tumor between 5cm to 15cm
* No portal vein trunk tumoral thrombus or inferior vena cava tumoral thrombus
* With arteriovenous fistula or arterioportal shunt fistula that can be completely embolized
* Child-Pugh class A or B/Child score \> 7;ECOG score \< 2
* Tolerable coagulation function or reversible coagulation disorders
* Laboratory examination test: WBC≥3.0×10E9/L; Hb≥3.0×10E9/L; PLT ≥50×10E9/L; INR \< 2.3 or PT\< 16.5s; Cr ≤ 145.5 umul/L
* Signed informed consent before recruiting
Exclusion Criteria:
* Diffused HCC
* With portal vein trunk tumoral thrombus
* With inferior vena cava tumoral thrombus or hepatic vein tumor thrombus
* With lymphatic metastasis or extra hepatic metastasis
* Child-Pugh class C and can't be improved by expectant treatment
* Untreatable coagulation disorders, severe hemogram abnormal and bleeding tendency
* Massive intractable ascites
* ECOG score \> 2
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02964260
Study Brief:
Protocol Section:
NCT02964260